A

AviadoBio

57 employees

AviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care

Date founded

2019

Funding rounds raised

Total raised

$78M

from 8 investors over 8 rounds

A

AviadoBio raised $78M on December 2, 2021

Investors: Monograph Capital, EQT Life Sciences, F-Prime Capital Partners, The Dementia Discovery Fund and Advent Life Sciences

A

AviadoBio raised $16M on January 1, 2020

Investors: F-Prime Capital Partners, The Dementia Discovery Fund and Advent Life Sciences

FAQ